# Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

> **NCT00618813** · NA · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 35 (actual)

## Conditions studied

- Ewing Sarcoma of Bone
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

## Interventions

- **OTHER:** radiation therapy
- **OTHER:** therapeutic conventional surgery
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** cyclophosphamide
- **DRUG:** vincristine sulfate
- **DRUG:** topotecan hydrochloride
- **BIOLOGICAL:** filgrastim

## Key facts

- **NCT ID:** NCT00618813
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618813, "Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00618813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*